MOLLIE STEINER: Open Payments
NPI 1750161071 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 41 payments from 19 companies in 2025. Trend: 2023 $668 · 2024 $1,344 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $170 |
| Dendreon Pharmaceuticals LLC | 6 | $158 |
| Endo USA, Inc. | 6 | $93 |
| PFIZER INC. | 4 | $83 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Ferring Pharmaceuticals Inc. | 4 | $65 |
| Janssen Biotech, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| TOLMAR, INC. | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
Products named: PROVENGE, Axonics, Xtandi, AVEED, ADSTILADRIN, GEMTESA, General - Erectile Dysfunction, Nubeqa.
Industry payments across NC — which companies pay providers there.
